WO2012174312A3 - Benzimidazole derivatives as antiviral agents - Google Patents
Benzimidazole derivatives as antiviral agents Download PDFInfo
- Publication number
- WO2012174312A3 WO2012174312A3 PCT/US2012/042558 US2012042558W WO2012174312A3 WO 2012174312 A3 WO2012174312 A3 WO 2012174312A3 US 2012042558 W US2012042558 W US 2012042558W WO 2012174312 A3 WO2012174312 A3 WO 2012174312A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antiviral agents
- benzimidazole derivatives
- formulas
- iii
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Provided are compounds of Formulas I, II, III, IV, V, and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV). Also provided are synthetic intermediates, methods for preparing the compounds of any of Formulas I, II, III, IV and V or a pharmaceutically acceptable salt or solvate thereof, and compositions thereof and for their therapeutic uses.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161497113P | 2011-06-15 | 2011-06-15 | |
US61/497,113 | 2011-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012174312A2 WO2012174312A2 (en) | 2012-12-20 |
WO2012174312A3 true WO2012174312A3 (en) | 2013-02-28 |
Family
ID=47357751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/042558 WO2012174312A2 (en) | 2011-06-15 | 2012-06-15 | Benzimidazole derivatives as antiviral agents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012174312A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI574962B (en) | 2012-11-14 | 2017-03-21 | 加拓科學公司 | Heteroaromatic compounds as pi3 kinase modulators and methods of use |
KR102148681B1 (en) | 2013-02-21 | 2020-08-27 | 칼리토르 사이언시즈, 엘엘씨 | Heteroaromatic compounds as pi3 kinase modulators |
CN103435618B (en) * | 2013-08-22 | 2016-03-23 | 中国药科大学 | A kind of method of synthesizing fused heterocyclic compound |
GB201416754D0 (en) | 2014-09-23 | 2014-11-05 | Mission Therapeutics Ltd | Novel compounds |
CN105218413A (en) * | 2015-08-12 | 2016-01-06 | 诚达药业股份有限公司 | Prepare the method for aromatic sulphonic acid compounds |
WO2017040993A1 (en) * | 2015-09-03 | 2017-03-09 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of dyrk1a and uses thereof |
WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
CA3075477A1 (en) * | 2017-08-07 | 2019-02-14 | Joint Stock Company "Biocad" | Novel heterocyclic compounds as cdk8/19 inhibitors |
RU2739489C2 (en) * | 2018-03-06 | 2020-12-24 | Закрытое Акционерное Общество "Биокад" | Novel heterocyclic compounds as cdk8/19 inhibitors |
CA3104760C (en) * | 2018-06-26 | 2023-09-26 | Kpc Pharmaceuticals, Inc. | Benzimidazole derivatives and use thereof as idh1 inhibitors |
CN110551101B (en) * | 2019-08-28 | 2020-11-24 | 沈阳药科大学 | 1. 6-disubstituted-benzo five-membered heterocyclic derivative and application thereof |
WO2021180219A1 (en) * | 2020-03-13 | 2021-09-16 | 挪贝肽医药科技(上海)有限公司 | Anti-coronavirus effect and application of pi4k inhibitor |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6166219A (en) * | 1995-12-28 | 2000-12-26 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
US20070093659A1 (en) * | 2003-12-18 | 2007-04-26 | Jean-Francois Bonfanti | Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
US20090163489A1 (en) * | 2007-12-19 | 2009-06-25 | Shon Booker | Inhibitors of PI3 kinase |
US7687638B2 (en) * | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
WO2010100144A1 (en) * | 2009-03-04 | 2010-09-10 | Merck Serono S.A. | Fused bicyclic compounds as inhibitors for pi3 kinase |
WO2010133318A1 (en) * | 2009-05-20 | 2010-11-25 | Cellzome Ag | Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins |
-
2012
- 2012-06-15 WO PCT/US2012/042558 patent/WO2012174312A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6166219A (en) * | 1995-12-28 | 2000-12-26 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
US20070093659A1 (en) * | 2003-12-18 | 2007-04-26 | Jean-Francois Bonfanti | Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
US7687638B2 (en) * | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
US20090163489A1 (en) * | 2007-12-19 | 2009-06-25 | Shon Booker | Inhibitors of PI3 kinase |
WO2010100144A1 (en) * | 2009-03-04 | 2010-09-10 | Merck Serono S.A. | Fused bicyclic compounds as inhibitors for pi3 kinase |
WO2010133318A1 (en) * | 2009-05-20 | 2010-11-25 | Cellzome Ag | Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins |
Also Published As
Publication number | Publication date |
---|---|
WO2012174312A2 (en) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012174312A3 (en) | Benzimidazole derivatives as antiviral agents | |
WO2011041713A3 (en) | Piperazinyl antiviral agents | |
HRP20211224T1 (en) | Pyrimidine derivatives for the treatment of viral infections | |
PH12018501736A1 (en) | Tetracyclic pyridone compounds as antivirals | |
PH12015500749A1 (en) | 2`chloro nucleoside analogs for hcv infection | |
MX2022013596A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use. | |
PH12014502739A1 (en) | Macrocyclic inhibitors of flaviviridae viruses | |
NZ703040A (en) | Macrocyclic inhibitors of flaviviridae viruses | |
NZ703066A (en) | Macrocyclic inhibitors of flaviviridae viruses | |
WO2012125926A3 (en) | Tetracyclic xanthene derivatives and methods of use thereof for the treatment of viral diseases | |
EA201290053A1 (en) | FLAVIVIRIDAE VIRUS INHIBITORS | |
WO2012142093A3 (en) | 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
NZ631762A (en) | 5-membered heteroaryls and their use as antiviral agents | |
WO2012166716A3 (en) | Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections | |
MX2013006475A (en) | Macrocyclic inhibitors of flaviviridae viruses. | |
UA108221C2 (en) | THIOPHENE-2-CARBIC ACID DERIVATIVES AS FLAVIVIRIDAE VIRUS INHIBITORS | |
GEP20156263B (en) | Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof | |
BR112013007696A2 (en) | compound, pharmaceutical composition, uses of said compound and said composition | |
NZ628445A (en) | Antiviral compounds with a heterotricycle moiety | |
MX2012008211A (en) | Inhibitors of flaviviridae viruses. | |
NZ603310A (en) | Heterocyclic flaviviridae virus inhibitors | |
UY31685A (en) | ANTIVIRAL COMPOUNDS, COMPOSITIONS AND METHODS TO USE THEM | |
IN2012DN01855A (en) | ||
CR11248A (en) | Anti-viral compounds, compositions and methods of use | |
JO3281B1 (en) | Benzofuran Compounds for the Treatment of Hepatitis C Virus Infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12800521 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM F1205 DATED 02-04-2014) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12800521 Country of ref document: EP Kind code of ref document: A2 |